China Shineway Pharmaceutical Group Limited (2877.HK)

HKD 7.26

(0.28%)

Total Assets Summary of China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited's latest annual total assets in 2023 was 9.57 Billion CNY , up 16.3% from previous year.
China Shineway Pharmaceutical Group Limited's latest quarterly total assets in 2023 FY was 9.57 Billion CNY , up 16.3% from previous quarter.
China Shineway Pharmaceutical Group Limited reported annual total assets of 8.23 Billion CNY in 2022, up 14.27% from previous year.
China Shineway Pharmaceutical Group Limited reported annual total assets of 7.2 Billion CNY in 2021, down -0.13% from previous year.
China Shineway Pharmaceutical Group Limited reported quarterly total assets of 8.9 Billion CNY for 2023 Q2, down 0.0% from previous quarter.
China Shineway Pharmaceutical Group Limited reported quarterly total assets of 9.57 Billion CNY for 2023 FY, up 16.3% from previous quarter.

Annual Total Assets Chart of China Shineway Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Total Assets of China Shineway Pharmaceutical Group Limited (2023 - 2003)

Year	Total Assets	Total Assets Growth
2023	9.57 Billion CNY	16.3%
2022	8.23 Billion CNY	14.27%
2021	7.2 Billion CNY	-0.13%
2020	7.21 Billion CNY	1.15%
2019	7.13 Billion CNY	5.94%
2018	6.73 Billion CNY	1.0%
2017	6.66 Billion CNY	3.09%
2016	6.46 Billion CNY	5.07%
2015	6.15 Billion CNY	4.16%
2014	5.9 Billion CNY	2.95%
2013	5.73 Billion CNY	20.98%
2012	4.74 Billion CNY	8.36%
2011	4.37 Billion CNY	10.19%
2010	3.97 Billion CNY	21.47%
2009	3.26 Billion CNY	34.76%
2008	2.42 Billion CNY	0.74%
2007	2.4 Billion CNY	19.97%
2006	2 Billion CNY	8.81%
2005	1.84 Billion CNY	17.5%
2004	1.57 Billion CNY	148.85%
2003	631.06 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2023 Q4	9.57 Billion CNY	0.0%
2023 Q2	8.9 Billion CNY	0.0%
2023 FY	9.57 Billion CNY	16.3%
2022 FY	8.23 Billion CNY	14.27%
2022 Q2	7.46 Billion CNY	0.0%
2022 Q4	8.23 Billion CNY	0.0%
2021 Q2	7.03 Billion CNY	0.0%
2021 FY	7.2 Billion CNY	-0.13%
2021 Q4	7.2 Billion CNY	0.0%
2020 FY	7.21 Billion CNY	1.15%
2020 Q4	7.21 Billion CNY	0.0%
2020 Q2	7.43 Billion CNY	0.0%
2019 FY	7.13 Billion CNY	5.94%
2019 Q2	6.66 Billion CNY	0.0%
2019 Q4	7.13 Billion CNY	0.0%
2018 Q4	6.73 Billion CNY	0.0%
2018 FY	6.73 Billion CNY	1.0%
2018 Q2	6.64 Billion CNY	0.0%
2017 Q4	6.66 Billion CNY	0.0%
2017 Q2	6.4 Billion CNY	0.0%
2017 FY	6.66 Billion CNY	3.09%
2016 FY	6.46 Billion CNY	5.07%
2016 Q4	6.46 Billion CNY	0.0%
2016 Q2	6.1 Billion CNY	0.0%
2015 FY	6.15 Billion CNY	4.16%
2015 Q4	6.15 Billion CNY	0.0%
2015 Q2	5.79 Billion CNY	0.0%
2014 Q4	5.9 Billion CNY	0.0%
2014 FY	5.9 Billion CNY	2.95%
2014 Q2	6.06 Billion CNY	0.0%
2013 Q2	4.83 Billion CNY	0.0%
2013 FY	5.73 Billion CNY	20.98%
2013 Q4	5.73 Billion CNY	0.0%
2012 Q4	4.74 Billion CNY	0.0%
2012 FY	4.74 Billion CNY	8.36%
2012 Q2	4.43 Billion CNY	0.0%
2011 Q2	4.15 Billion CNY	0.0%
2011 Q4	4.37 Billion CNY	0.0%
2011 FY	4.37 Billion CNY	10.19%
2010 Q4	3.97 Billion CNY	0.0%
2010 FY	3.97 Billion CNY	21.47%
2010 Q2	3.52 Billion CNY	0.0%
2009 FY	3.26 Billion CNY	34.76%
2009 Q4	3.26 Billion CNY	0.0%
2008 FY	2.42 Billion CNY	0.74%
2007 FY	2.4 Billion CNY	19.97%
2006 FY	2 Billion CNY	8.81%
2005 FY	1.84 Billion CNY	17.5%
2004 FY	1.57 Billion CNY	148.85%
2003 FY	631.06 Million CNY	0.0%

Peer Total Assets Comparison of China Shineway Pharmaceutical Group Limited

Name	Total Assets	Total Assets Difference
Pak Fah Yeow International Limited	907.46 Million HKD	-955.026%
Grand Pharmaceutical Group Limited	22.51 Billion HKD	57.478%
Extrawell Pharmaceutical Holdings Limited	1.28 Billion HKD	-643.791%
Wai Yuen Tong Medicine Holdings Limited	2.09 Billion HKD	-356.969%
Qianhai Health Holdings Limited	478.11 Million HKD	-1902.437%
Lee's Pharmaceutical Holdings Limited	2.89 Billion HKD	-231.204%
Essex Bio-Technology Limited	2.82 Billion HKD	-238.596%
Tongfang Kontafarma Holdings Limited	1.72 Billion HKD	-454.264%
PuraPharm Corporation Limited	843.96 Million HKD	-1034.409%
SSY Group Limited	11.96 Billion HKD	19.992%
JBM (Healthcare) Limited	1.38 Billion HKD	-589.423%
Jacobson Pharma Corporation Limited	3.48 Billion HKD	-174.574%
China Resources Pharmaceutical Group Limited	271.69 Billion HKD	96.476%